This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Gilead Sciences Blowout Earnings Shock the Street: StockTwits

NEW YORK (TheStreet) -- Earning season is kicking into high gear and after today's close, we saw an entire smorgasbord of earnings releases and trader reactions.

So many good earns at first glance $SKX, $SMCI, $SWKS, $VMW - BeatTheStreet (@BeatShort) Apr. 22 at 02:27 PM

But the undisputed winner of the day is no doubt Gilead Sciences  (GILD), who simply demolished analysts' estimates. This was very good news to the overwhelmingly bullish crowd on StockTwits which dominated discussion:

Screen Shot 2014-04-22 at 2.21.16 PM

$GILD with a gargantuan EPS beat - Derald Muniz (@1nvestor) Apr. 22 at 02:03 PM

The ramifications of news like this out of major biotech players has some interpreting the meaning to be bullish for the broader markets:

It's hard to get to bearish on the market when bio's are ripping. $IBB $SPY $IWM $QQQ. Yes market overbought, but could chop instead of drop - SassySPY (@Sassy_SPY) Apr. 22 at 02:23 PM

After an initial trading halt, shares of Gilead resumed as much as 5% higher in after-hours trade: And many expect the 'upgrade parade' to begin tomorrow morning:

$GILD wait for massive upgrades tomorrow - Joe C. (@TraderJoe4) Apr. 22 at 02:39 PM

$GILD it'll climb - with earnings like that and EOY earnings adjustments coming, analyst upgrades, shorts will need to cover. hold for a bit - Jarrod Silcox (@StockSurfing) Apr. 22 at 02:34 PM

Possibly adding fuel to the fire is the increasingly high level of short positions held in Gilead that will need to be bought in at some point:

$GILD 92mm shares short http://stks.co/b0SpL - RAS (@simonsays452) Apr. 22 at 02:23 PM

However, cooler heads were less impressed as they looked past the headline numbers and dug deeper:

$GILD Q1 sales, other than sovaldi, shows weakness in a number of products. - Brian Kelly (@bdwight1) Apr. 22 at 02:39 PM

And given the price reaction, some think maybe investors will be less excited once the original euphoria wears off:

$GILD smaller reaction than expected. I expected 8% pop on ER. - So Generous (@sogenerous) Apr. 22 at 02:39 PM

Follow me on StockTwits: @chicagosean

This article represents the opinion of a contributor and not necessarily that of TheStreet or its editorial staff.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,096.52 -17.02 -0.10%
S&P 500 1,988.33 +4.80 0.24%
NASDAQ 4,474.1720 +18.1560 0.41%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs